Summarization: Breast cancer is a complex disease with heterogeneity between patients regarding prognosis and treatment response. Recent progress in advanced molecular biology techniques and the development of efficient methods for database mining lead to the discovery of promising novel biomarkers for prognosis and prediction of breast cancer. In this paper, we applied three computational algorithms (RFE-LNW, Lasso and FSMLP) to one microarray dataset for breast cancer and compared the obtained gene signatures with a recently described disease-agnostic tool, the Genotator. We identified a panel of 152 genes as a potential prognostic signature and the ERRFI1 gene as possible biomarker of breast cancer disease.Παρουσιάστηκε στο: Annual Inter...
Background/Aim: The aim of the present study was to identify key pathways and genes in breast cancer...
The technology of cDNA microarrays has given us the possibility to monitor the state of cells by mea...
[Motivation]: Modern genomic technologies allow us to perform genome-wide analysis to find gene mark...
Cancer patients are often overtreated because of a failure to identify low-risk cancer patients. Thu...
Abstract Background Breast cancer is a heterogeneous disease, presenting with a wide range of histol...
Analysis by DNA microarrays has led to the identification of molecular subtypes of breast carcinomas...
NoTriple-negative breast cancers (TNBC) are clinically heterogeneous, an aggressive form of breast c...
Cancer patients are often overtreated because of a failure to identify low-risk cancer patients. Thu...
Numerous prognostic gene expression signatures for breast cancer were generated previously with few ...
Using primary tumor gene expression has been shown to have the ability of finding metastasis-driving...
Numerous prognostic gene expression signatures for breast cancer were generated previously with few ...
Cancer is a genetic disease that arises when a cell acquires unlimited growth potential through a se...
PurposeTo identify a gene signature for the prognosis of breast cancer using high-throughput analysi...
Clinical applications of gene expression signatures in breast cancer prognosis still remain limited ...
Microarrays are being increasingly used in cancer research for a better understanding of the molecul...
Background/Aim: The aim of the present study was to identify key pathways and genes in breast cancer...
The technology of cDNA microarrays has given us the possibility to monitor the state of cells by mea...
[Motivation]: Modern genomic technologies allow us to perform genome-wide analysis to find gene mark...
Cancer patients are often overtreated because of a failure to identify low-risk cancer patients. Thu...
Abstract Background Breast cancer is a heterogeneous disease, presenting with a wide range of histol...
Analysis by DNA microarrays has led to the identification of molecular subtypes of breast carcinomas...
NoTriple-negative breast cancers (TNBC) are clinically heterogeneous, an aggressive form of breast c...
Cancer patients are often overtreated because of a failure to identify low-risk cancer patients. Thu...
Numerous prognostic gene expression signatures for breast cancer were generated previously with few ...
Using primary tumor gene expression has been shown to have the ability of finding metastasis-driving...
Numerous prognostic gene expression signatures for breast cancer were generated previously with few ...
Cancer is a genetic disease that arises when a cell acquires unlimited growth potential through a se...
PurposeTo identify a gene signature for the prognosis of breast cancer using high-throughput analysi...
Clinical applications of gene expression signatures in breast cancer prognosis still remain limited ...
Microarrays are being increasingly used in cancer research for a better understanding of the molecul...
Background/Aim: The aim of the present study was to identify key pathways and genes in breast cancer...
The technology of cDNA microarrays has given us the possibility to monitor the state of cells by mea...
[Motivation]: Modern genomic technologies allow us to perform genome-wide analysis to find gene mark...